Sonas pHARMA

Neurosciences

This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.

Aelis Farma

The company develops pharmacological treatments for brain diseases including cannabis use disorders and cognitive deficits for patients with unmet medical needs.

Epidiolex

This company develops a prescription cannabidiol oral solution to treat seizures associated with Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex in patients.

EpilepsyGTx

This company develops precision gene therapies for patients with focal refractory epilepsy to provide seizure freedom.

IAMA Therapeutics

This company develops small molecule drugs to treat neurodevelopmental and central nervous system disorders for patients with autism and epilepsy.

Noema Pharma

This company develops clinical-stage therapeutic products for patients with central nervous system disorders and orphan neurological conditions.

Pleo Pharma

This pharmaceutical company develops oral treatments to mitigate cannabis withdrawal symptoms for adult patients with cannabis use disorder.

Enemsa Pharma

This company develops small-molecule neuroprotective therapies and combination drugs to treat patients with rare neurodegenerative and cardiopulmonary diseases.